Skip to main content
Erschienen in: International Urology and Nephrology 5/2021

02.01.2021 | Urology - Original Paper

Detrusor underactivity influences the efficacy of TURP in patients with BPO

verfasst von: Yan Zhu, Yao-Rui Zhao, Ping Zhong, Bao-Min Qiao, Zhi-Qiang Yang, Yuan-Jie Niu

Erschienen in: International Urology and Nephrology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the effect of detrusor underactivity on the efficacy of TURP in patients with benign prostate obstruction.

Methods

A retrospective study of 350 patients with benign prostate obstruction who underwent TURP was carried out. Different degrees of bladder outlet obstruction were grouped by the bladder outlet obstruction index. ROC curves were used to calculate the optimal cut-off point for the bladder contractility index used to divide the DU patients into mild DU and severe DU patients. The effect of DU on the efficacy of TURP in benign prostate obstruction patients was studied by comparing the subjective and objective parameters preoperatively and 3 months postoperatively between severe DU, mild DU and non-DU benign prostate obstruction patients in two obstruction groups (20 ≤ BOOI < 40 and BOOI ≥ 40).

Results

According to the ROC curve, the optimal cut-off point for the bladder contractility index was 82; thus, 69 patients were considered mild DU patients (82 ≤ BCI < 100), 67 patients were considered severe DU patients (BCI < 82), and 214 patients were considered non-DU patients (BCI ≥ 100). Both the postoperative subjective and objective parameters of the non-DU, mild DU and severe DU patients significantly improved in two obstruction groups. However, in the 20 ≤ BOOI < 40 group, the successful improvement rates for the IPSS, IPSS-S, IPSS-V, QoL and fQmax in the severe DU patients were only 38.2%, 38.2%, 44.1%, 41.2% and 38.2%, respectively.

Conclusion

Patients with varying degrees of benign prostate obstruction can benefit from TURP, but for patients with severe DU in the 20 ≤ BOOI < 40 group, TURP should be considered only after deliberation.
Literatur
1.
Zurück zum Zitat Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRef Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRef
2.
Zurück zum Zitat Sarma AV, Wei JT (2012) Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med 367:248–257CrossRef Sarma AV, Wei JT (2012) Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med 367:248–257CrossRef
3.
Zurück zum Zitat Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50:969–979 (discussion 980)CrossRef Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50:969–979 (discussion 980)CrossRef
4.
Zurück zum Zitat Kanik EA, Erdem E, Abidinoglu D, Acar D, Akbay E, Ulusoy E (2004) Can the outcome of transurethral resection of the prostate be predicted preoperatively. Urology 64:302–305CrossRef Kanik EA, Erdem E, Abidinoglu D, Acar D, Akbay E, Ulusoy E (2004) Can the outcome of transurethral resection of the prostate be predicted preoperatively. Urology 64:302–305CrossRef
5.
Zurück zum Zitat Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 96:1301–1306CrossRef Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 96:1301–1306CrossRef
6.
Zurück zum Zitat Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G et al (2018) Terminology report from the international continence society (ICS) working group on underactive bladder (UAB). Neurourol Urodyn 37:2928–2931CrossRef Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G et al (2018) Terminology report from the international continence society (ICS) working group on underactive bladder (UAB). Neurourol Urodyn 37:2928–2931CrossRef
7.
Zurück zum Zitat Li X, Liao L (2016) Updates of underactive bladder: a review of the recent literature. Int Urol Nephrol 48:919–930CrossRef Li X, Liao L (2016) Updates of underactive bladder: a review of the recent literature. Int Urol Nephrol 48:919–930CrossRef
8.
Zurück zum Zitat Osman NI, Esperto F, Chapple CR (2018) Detrusor underactivity and the underactive bladder: a systematic review of preclinical and clinical studies. Eur Urol 74:633–643CrossRef Osman NI, Esperto F, Chapple CR (2018) Detrusor underactivity and the underactive bladder: a systematic review of preclinical and clinical studies. Eur Urol 74:633–643CrossRef
9.
Zurück zum Zitat Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84:14–15CrossRef Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84:14–15CrossRef
10.
Zurück zum Zitat Lee KH, Kuo HC (2019) Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology 123:235–241CrossRef Lee KH, Kuo HC (2019) Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology 123:235–241CrossRef
11.
Zurück zum Zitat Rademakers KL, van Koeveringe GA, Oelke M (2016) Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate. Curr Opin Urol 26:3–10CrossRef Rademakers KL, van Koeveringe GA, Oelke M (2016) Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate. Curr Opin Urol 26:3–10CrossRef
12.
Zurück zum Zitat Homma Y, Kawabe K, Tsukamoto T et al (1996) Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol 3(4):267–273CrossRef Homma Y, Kawabe K, Tsukamoto T et al (1996) Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol 3(4):267–273CrossRef
13.
Zurück zum Zitat van der Wijden FC, de Angst IB, Lamers R, Cuypers M, de Vries M, van Melick H et al (2018) Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int 124:124–133CrossRef van der Wijden FC, de Angst IB, Lamers R, Cuypers M, de Vries M, van Melick H et al (2018) Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int 124:124–133CrossRef
14.
Zurück zum Zitat Oh MM, Kim JW, Kim JJ, du Moon G (2012) Is there a correlation between the outcome of transurethral resection of prostate and preoperative degree of bladder outlet obstruction. Asian J Androl 14:556–559CrossRef Oh MM, Kim JW, Kim JJ, du Moon G (2012) Is there a correlation between the outcome of transurethral resection of prostate and preoperative degree of bladder outlet obstruction. Asian J Androl 14:556–559CrossRef
15.
Zurück zum Zitat Hoag N, Gani J (2015) Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J 19:185–189CrossRef Hoag N, Gani J (2015) Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J 19:185–189CrossRef
16.
Zurück zum Zitat Chang YH, Siu JJ, Hsiao PJ, Chang CH, Chou EC (2018) Review of underactive bladder. J Formos Med Assoc 117:178–184CrossRef Chang YH, Siu JJ, Hsiao PJ, Chang CH, Chou EC (2018) Review of underactive bladder. J Formos Med Assoc 117:178–184CrossRef
17.
Zurück zum Zitat Aldamanhori R, Osman NI, Chapple CR (2018) Underactive bladder: pathophysiology and clinical significance. Asian J Urol 5:17–21CrossRef Aldamanhori R, Osman NI, Chapple CR (2018) Underactive bladder: pathophysiology and clinical significance. Asian J Urol 5:17–21CrossRef
18.
Zurück zum Zitat Donkelaar SCT, Rosier P, de Kort L (2017) Comparison of three methods to analyze detrusor contraction during micturition in men over 50 years of age. Neurourol Urodyn 36:2153–2159CrossRef Donkelaar SCT, Rosier P, de Kort L (2017) Comparison of three methods to analyze detrusor contraction during micturition in men over 50 years of age. Neurourol Urodyn 36:2153–2159CrossRef
19.
Zurück zum Zitat Yu Z, Li J, Li Z, Hou R (2015) Photoselective vaporization of the prostate and simultaneous suprapubic cystostomy for the treatment of benign prostatic hyperplasia in patients with mild to severe detrusor underactivity. Urol Int 95:269–275CrossRef Yu Z, Li J, Li Z, Hou R (2015) Photoselective vaporization of the prostate and simultaneous suprapubic cystostomy for the treatment of benign prostatic hyperplasia in patients with mild to severe detrusor underactivity. Urol Int 95:269–275CrossRef
20.
Zurück zum Zitat Griffiths DJ (1991) Assessment of detrusor contraction strength or contractility. Neurourol Urodyn 10:1–18CrossRef Griffiths DJ (1991) Assessment of detrusor contraction strength or contractility. Neurourol Urodyn 10:1–18CrossRef
21.
Zurück zum Zitat Lee SM, Hashim H (2018) Recent advances in the understanding and management of underactive bladder. F1000Res 7:437CrossRef Lee SM, Hashim H (2018) Recent advances in the understanding and management of underactive bladder. F1000Res 7:437CrossRef
Metadaten
Titel
Detrusor underactivity influences the efficacy of TURP in patients with BPO
verfasst von
Yan Zhu
Yao-Rui Zhao
Ping Zhong
Bao-Min Qiao
Zhi-Qiang Yang
Yuan-Jie Niu
Publikationsdatum
02.01.2021
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2021
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02750-1

Weitere Artikel der Ausgabe 5/2021

International Urology and Nephrology 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.